Science

The office coffee tastes like burnt pennies, and the printer is spitting out budget spreadsheets like it is angry at me personally. In the hearing rooms and the lobby corridors, researchers are doing what they always do: keeping the freezers cold, the grad students paid, and the clinical trials honest. And now the National Institutes of Health is taking a marker to one of the last clean pieces of public math in the federal grant machine: the payline.

NIH is moving away from published grant paylines

NIH has rolled out a unified funding strategy that, beginning with the January 2026 council round, stops treating traditional paylines as the default way to decide what gets funded. Instead of a clear cutoff tied to peer review scores, NIH says it will weigh a broader mix of factors: peer review information, alignment with NIH and institute priorities, investigator career stage, geographic distribution, and an applicant’s existing NIH funding portfolio. NIH leadership sells this as a way to make award decisions clearer and more consistent across institutes and centers. The policy is described in an NIH Extramural Nexus post and echoed in advisory council materials.

In isolation, the pitch sounds respectable: do not worship a single number, use judgment, read the critiques, fund what matters.

But I have been around enough bureaucracies to know what “more judgment” usually means.

Translation: more discretion means more room for influence

Translation: “We are discontinuing paylines” can land as “We are making it harder for outsiders to predict, audit, and contest our choices.” Paylines were never perfect, and exceptions happened. But they gave applicants and institutions a visible benchmark. It was not justice, but it was at least a receipt.

Now the receipt becomes a paragraph about “priorities,” “portfolio balance,” and “geographic distribution.” Those goals are not automatically bad. But they are squishy. And squishy is where capture lives.

Once “alignment with priorities” becomes central, applicants react like rational actors. They do not just do better science. They write to the priorities. They call the program officer more. They hire the grant consultant. They workshop language through university compliance. The grant starts to look less like peer review and more like a pitch deck.

Here is the mechanism: the score still exists, but the lever moves

Here is the mechanism: peer review still happens, but power shifts toward the internal decision layer where priorities and budgets get translated into winners and losers. NIH says it will consider peer review information “in its entirety” rather than using paylines to build pay plans, while institute directors retain delegated authority to decide what gets funded. Advisory council materials describe institutes and centers discontinuing use of paylines while weighing scores alongside priorities, career stage, and geography.

That is not a small procedural tweak. It is a redistribution of uncertainty. And uncertainty is not evenly distributed.

Follow the money: who wins when the rules get less legible

Follow the money: when the rules start to feel like vibes, the system rewards proximity, not just brilliance. Deep-pocketed universities can float staff, pay bridge funding, and keep people employed while “holistic” decisions churn. Smaller institutions cannot. When predictability shrinks, they do not just lose a project. They lose people.

Meanwhile, every time a public funding system gets harder to navigate, the private sector shows up like a smiling repo man: foundations pick and choose, venture capital cherry-picks, industry money pulls research toward corporate priorities. The public mission gets squeezed.

The quiet part: priorities can become a loyalty test

The quiet part: once “priorities” become the center of gravity, they can be politicized without rewriting a statute. “Unified strategy” sounds like clean whiteboard talk. In practice, priorities are where ideology can hide in plain sight, used to uplift neglected needs or to punish research that makes powerful people uncomfortable.

Maybe NIH can run this with integrity. But if NIH wants trust, it has to earn it with sunlight, not slogans. Congress should demand transparent reporting on award decisions under the new framework. Inspectors general should audit for bias and inconsistency. Watchdogs should FOIA criteria and decision memos. Universities should organize their research workforce to push back against politicized “priorities.” If NIH is going to kill the payline, what exact safeguards keep lobbyists from drawing the new invisible line?

I am staring at a stack of printer paper that smells like stale coffee and betrayal. This is the kind of paperwork that arrives right before someone tells a postdoc their project is “paused” for reasons that have nothing to do with evidence. Outside: neon and sirens. Inside: committee-room air, dry enough to make you forget you are supposed to breathe.

On February 19, 2026, House Democrats sent the White House a letter asking for something that should be automatic in a functioning democracy: receipts. They want transparency on the President’s Council of Advisors on Science and Technology (PCAST). They want the administration to stop treating federal research like a discretionary tip jar. The letter is addressed to OSTP Director Michael Kratsios and to David Sacks, the White House special advisor for AI and crypto and chair of PCAST.

Two days later, on February 21, 2026, the question is not whether the letter is polite. It is. The question is why the United States has to beg for a public record of who is advising the President on science while the same White House sells a glossy “innovation” story.

What lawmakers say is missing

The complaint is basic. PCAST was reestablished in January 2025, but there are no recent public records that clearly document progress or even current membership, and publicly available PCAST materials appear dated. The lawmakers ask for a formal report: plans, updates, membership, initiatives, meeting schedule, achievements. The stuff you publish when government is not being run like a private club.

The letter also points to the stakes: the President’s FY2026 budget proposal seeks to reduce total federal R&D by 22% compared to FY2025 continuing resolution levels, with at least 20% reductions proposed for NASA, NSF, NIH, and DOE, and a proposed 43% cut to NIST. It notes appropriators rejected drastic cuts in a bipartisan spending package, but warns funding still may not be enough to maintain competitiveness.

Translation: transparency means “stop ghosting the public”

Translation: when members of Congress say “provide a formal report,” they mean stop going quiet while you steer the country’s science priorities out of public view.

PCAST is supposed to help set national science and technology priorities. It is not supposed to be a mystery box. And symbolism matters: a council chaired by the White House’s special advisor for AI and crypto is operating with low public visibility, right as AI policy becomes a corporate gold rush. Government-by-omniscient-silence is not a clerical mistake. It is a tactic.

Here is the mechanism: starve the commons, then sell “partnership”

Here is the mechanism: you squeeze public research funding, create uncertainty, then wave “efficiency” and “merit” language like a badge. Universities and labs get pushed to hunt for private money to keep the lights on. The actors who can float the gap are not community colleges or state labs. The gap gets floated by big tech, big pharma, and defense contractors, and research agendas drift toward profitable products, proprietary models, and contracts.

Follow the money: subsidy now, control forever

Follow the money: federally funded science underpins private sector innovation. That is why the fight over federal R&D is vicious. The public is the seed corn. Corporations want the silo and the key. And when Congress has to write a letter to get basic transparency about the President’s science council, you can smell the incentive structure through the paper.

The quiet part

The quiet part: they want science that serves power, not people. Scientific integrity is not just clean datasets. It is visible governance. Publish membership. Publish meetings. Publish the agenda. Then bring it into oversight hearings under bright lights, because a council that leaves no fingerprints is a council that cannot be cross-examined.

My mic-drop is boring on purpose: subpoena the documents, audit the process, empower inspectors general, and make appropriations conditional on real transparency. Then let the research workforce organize like their livelihoods matter, because they do.

I keep thinking about the old library card catalog: wooden drawers, brass labels, and a civic assumption that access comes with rules. If somebody abused the system, the answer was not “build a faster catalog.” The answer was enforcement of the rules.

Washington, as usual, prefers the opposite order: build first, argue about limits later, ideally behind a euphemism and a locked committee door.

What DHS is trying to build

On February 20, WIRED reported that the Department of Homeland Security is moving toward consolidating facial recognition and other biometric tools into a single “matching engine,” based on records it reviewed. The idea: one system that can compare faces, fingerprints, iris scans, and more across DHS components, serving routine identity checks and investigative searches, and connecting agencies that do not currently share data easily.

Biometric Update also described a DHS Request for Information aimed at industry input for an enterprise biometric matching capability spanning major DHS components, including multimodal matching, adjustable thresholds, and extensive logging and auditability.

This is not science fiction. It is procurement, which is how policy sneaks into the building wearing a hard hat and carrying an invoice.

Why this is a power upgrade, not just a tech upgrade

WIRED’s reporting describes a department-wide system touching components such as CBP, ICE, TSA, USCIS, the Secret Service, and DHS headquarters, supporting missions like watch-listing and detention or removal operations. Centralization lowers friction, and friction is sometimes the last guardrail a free society has left.

WIRED also highlights a distinction that matters: verification (one-to-one, “are you who you claim?”) versus identification (one-to-many, “who is this person in the database?”). The second category is where false positives and mission creep tend to multiply.

Then there is the footnote that should not be a footnote: WIRED notes a placeholder indicating DHS wants to incorporate voiceprint analysis, without detailed plans for collection, storage, or search.

The Orwell check: “interoperability” as a permission slip

My Orwell check is simple: listen to the vocabulary. “Interoperability,” “modernization,” “enterprise solution.” Those are conference-badge words. In practice, they often mean broader access and easier searching.

And DHS itself has described what guardrails look like when they are written down. In a January 2025 archived post summarizing a 2024 update, DHS described Directive 026-11 as requiring bias and disparate impact testing, opt-out for U.S. citizens for non-law enforcement uses, a rule that facial recognition cannot be the sole basis for law or civil enforcement action, and oversight reviews by offices including the DHS Privacy Office and the Office for Civil Rights and Civil Liberties.

WIRED, however, describes DHS pursuing this consolidation after dismantling centralized privacy reviews and key limits on facial recognition. If that is accurate, the story is not only a bigger engine. It is fewer brakes.

The liberty ledger and the Paine test

The liberty ledger: DHS gains speed and a single window into multiple biometric workflows. The public takes the risk: travelers, immigrants, and anyone easiest to scan and hardest to defend. NIST’s face recognition testing has long underscored that performance and error rates vary with image quality, use case, and demographics. Adjustable thresholds are not just a technical knob. They are a constitutional decision.

The Paine test: does this expand liberty, or concentrate power? A department-wide biometric search box concentrates power by making broader searching cheaper and easier.

Guardrails to bolt on before “procurement” becomes “policy”

• Publish the governing rules: thresholds, authorized uses, retention limits, and redress mechanisms.
• Separate verification from investigative identification, with distinct legal standards and audits.
• Independent audits with public reporting, not just internal compliance memos.
• Meaningful due process: if you get flagged, you should be able to learn it, challenge it, and correct it.
• Explain, in plain language, what remains of the earlier opt-outs and oversight DHS once described, and what was removed.

Sunlight is not a nuisance. It is the operating system of self-government. So here is the question: if DHS is building a single biometric search box for multiple agencies, what exact, published rule stops it from becoming a national suspicion machine?

I smelled it before I finished the first paragraph. That familiar federal cocktail: a budget axe swinging in one hand, and “innovation” cologne sprayed with the other. The kind of situation where Washington unplugs people and then acts shocked when a shiny tool shows up pretending to be a miracle.

NIH: more AI use cases, fewer employees

According to federal inventory reporting and agency talk around NIH’s AI adoption, the trend line is clear: staffing shrinks while AI pilots grow. NIH’s headcount fell to roughly 17,000 employees in early 2026, down by more than 4,000 from just over a year earlier. At the same time, NIH’s reported AI use cases climbed to 124 in fiscal 2025, up from 82 in 2024, based on the HHS AI use-case inventory published under federal requirements.

Brick’s F-150 math: tools are fine, replacing the crew is not

I am not here to boo a calculator. I like tools. AI can absolutely be a tool. But when an agency that deals in life-and-death science loses thousands of workers and then leans harder on pilots, you do not get “efficiency.” You get shortcuts, burnout, and dashboards screaming “ALL GOOD” while the oil light flashes.

NIH officials and speakers have described AI work spanning:

• Administrative tasks (like analyzing grant portfolios)
• Research support and lab work
• Clinical assistance

A lot of it is still pilot or pre-deployment, meaning it is revving in the parking lot, not hauling a trailer across the country. And NIH folks have been blunt that scaling is the hard part, where messy data, foggy rules, and real accountability come due.

The vendor swamp and the “$1 deal” worry

Now for the villain: procurement gravity. NIH, like other agencies, has leaned on bundled buying efforts through GSA, including OneGov, launched in April 2025 to treat the federal government like one customer. Sounds clean in theory. In practice, it can become the classic trap: cheap up front, expensive forever.

One NIH technology leader raised concern about the “drug dealer model” of $1 deals that later sunset. Translation: free samples today, renewal shock tomorrow, after your workflows and training are already chained to the platform.

Small language models, big leverage

NIH speakers have discussed building domain-specific small language models trained on large NIH datasets (including Alzheimer’s data) so researchers can ask questions within a tight, controlled domain. That direction is promising. Small and auditable beats giant black-box oracle.

NIH is also running a generative AI community of practice with roughly 2,000 people, pushing training and careful use (including human-in-the-loop and data protection). Good guardrail talk. But guardrails take staff, time, and spine, especially across NIH’s 27 institutes and centers.

If you drain the workforce and replace it with pilots, you are not modernizing. You are outsourcing responsibility and praying the discount never ends.

The newsroom coffee tastes like burned budget hearings. My phone lights up with the kind of bad news that never comes with sirens because the damage is bureaucratic, quiet, and built for plausible deniability. Somewhere in a federal office, someone decided the threat is not the next outbreak. The threat is the vocabulary we use to warn you it is coming.

NIAID staff told to delete “biodefense” and “pandemic preparedness” from the website

This week, Nature reporting described a directive inside the National Institute of Allergy and Infectious Diseases (NIAID) to scrub the terms “biodefense” and “pandemic preparedness” from web pages, citing emails it says it obtained. Scientific American amplified that reporting. CIDRAP summarized it plainly: delete the words, deprioritize the work, and call it a reorganization.

Translation: a website scrub in Washington is not a typo fix. It is a power signal.

Translation: censorship with a lab coat

Translation: “scrub the words” means “scrub the mission.” It redraws the public-facing map of what NIAID does so later budget moves look like routine housekeeping. First you erase a phrase. Then you erase a program. Then you erase a grant line. Then you erase a career.

Yes, they will tell you it is about “focus,” “impact,” and “gold standard science.” CIDRAP notes NIH Director Jay Bhattacharya and coauthors have framed the shift as prioritizing diseases Americans “currently face,” alongside immunology, allergy, and autoimmune work. Those needs are real. That is not the point. You do not build a fire department by banning the word “fire” from the station door.

Here is the mechanism: erase the label, then starve the line item

Here is the mechanism: research priorities are set not only in labs, but in memos, websites, and budget narratives that define what counts as “core” versus “legacy.” If you want to downgrade a mission without owning the consequences, you make it harder to point to.

Once “pandemic preparedness” disappears from official language, future cuts get easier. Cancellations become “not aligned.” Whistleblowers become “confused.” The paper trail becomes fog.

CIDRAP also points to context: about a third of NIAID’s roughly $6.6 billion budget supports studies on pathogens of concern and protective measures against emerging infectious disease threats, alongside a broader NIH workforce reduction since January 2025 and the earlier idling of the White House Office of Pandemic Preparedness and Response Policy in June 2025. That is not an editing choice. That is a pattern.

Follow the money: costs migrate, chaos pays

Follow the money: when public health readiness shrinks, the bill does not vanish. It lands on nurses, teachers, warehouse workers, and families who cannot take unpaid leave. It lands on state budgets and hospital systems forced to improvise.

And the winners? Private vendors selling emergency fixes at premium prices. Political operators running on chaos they helped engineer. Industries that hate regulation and love an enforcement state too distracted to enforce anything.

The quiet part: make preparedness sound like a conspiracy genre

The quiet part is narrative control. If you can make “pandemic preparedness” sound like a discredited buzzword, you can treat the next warning like partisan noise and pre-discredit the people who will later say, “we told you.” Change the vocabulary and you make accountability questions harder to ask.

Congress should subpoena the emails. Inspectors general should audit the decision chain and any downstream grant reprioritizations. Scientific institutions should stop whispering and start naming the sabotage in plain English. Because if they are proud of this, why does it look like a back-alley rewrite instead of a public hearing?

Under the library fluorescents, everything looks like evidence, including our favorite national bedtime story: we can kick the legs out from under the future and still demand it arrive on schedule.

The latest warnings about a scientific brain drain are not mysterious. If you freeze or terminate research money midstream, the people trained to measure reality will measure the risk and relocate. They rarely slam doors. They just pack their notebooks.

Trump-era science cuts, grant churn, and a recruitment market overseas

Here is the plain-language version: federal science has been whipsawed, and early-career researchers are catching the worst of it. Grants get frozen or terminated. Hiring slows. Programs narrow by politics instead of peer review. Then officials look around like morale vanished on its own.

Nature quantified the chaos: 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended, with more than 7,800 grants affected over the course of 2025. Courts have ordered thousands reinstated, but Nature notes it is unclear how many scientists have actually received restored funds. It also reports roughly 2,600 grants had not been reinstated or unfrozen, totaling $1.4 billion in unspent funding.

That is not an abstract culture-war bar chart. That is a lab shutting down. That is a clinical team being told the money is here, then not here, then maybe here again after a judge intervenes.

Meanwhile, Europe is not treating this like a spectator sport. Inside Higher Ed reported European governments and universities building recruitment efforts aimed at US-based researchers, explicitly selling stability and, in some cases, refuge from political pressure. If you are holding a mortgage-sized grant that just got turned into confetti, “stability” is not a slogan. It is a plan.

What this breaks (and why taxpayers should care)

The US government is not just a checkbook for science. It is the referee. When politics starts grading the papers, incentives rot. Not because scientists are saints, but because they are human and respond to the environment you build.

And the disrupted work is not a boutique hobby. The CDC estimates more than 2.8 million antimicrobial-resistant infections a year in the US and more than 35,000 deaths. When you add C. diff, the CDC puts the total above 3 million infections and 48,000 deaths.

The Paine test and the Orwell check

• The Paine test: when grantmaking becomes a loyalty test, power concentrates in opaque executive discretion, not transparent rules you can challenge.
• The Orwell check: “efficiency” and “accountability” are fine words until they show up without clear metrics, published criteria, or a real appeals process.

We can debate priorities and fraud controls. We should. But yanking research support around like a steering wheel in an ice storm is not oversight. It is sabotage with paperwork.

I smelled it before I finished the first sentence. That hot-paper, fresh-ink aroma of a brand-new lawsuit, like somebody cracked open a three-ring binder in a windowless conference room and called it “public health.” Somewhere, a lawyer in a fleece vest is high-fiving a grant writer, and my old F-150 is blinking its headlights like: here we go again.

Because the climate courthouse carnival is back in town. Same jugglers, same megaphone, same donation links. This time, they are suing the EPA after Trump’s EPA hit the big red reset button on the 2009 greenhouse gas “endangerment finding,” the legal keystone that helped Washington treat your tailpipe like a federal crime scene.

What happened (dates, receipts, and the real meat)

• February 12, 2026: EPA finalized a rule rescinding the 2009 greenhouse gas endangerment finding as it relates to motor vehicles and also repealed vehicle greenhouse gas emissions standards and related requirements. EPA described it as a major deregulatory move with big claimed savings.
• February 18, 2026: A coalition of public health and environmental groups filed suit in the U.S. Court of Appeals for the D.C. Circuit challenging that repeal. Associated Press described it as a direct attack on the legal foundation of federal climate rules under the Clean Air Act, with the groups arguing the repeal is unlawful and ignores the science behind the 2009 finding.

So yes, it is official: the endangerment finding is not just a scientific argument anymore. It is a political crowbar. One side treats it like a sacred tablet. The other side treats it like a bureaucratic coupon book that never should have scanned at the checkout line of American life.

The swamp’s favorite sport: regulating your choices through your exhaust pipe

Normal-human translation: this is the Washington magic trick where a gas becomes the villain, then your minivan becomes the suspect, then your family budget becomes collateral damage. It is like a guy at a cookout declaring charcoal a public health emergency, then fining you for grilling.

And do not miss the spreadsheet cage match. AP also reported competing cost claims around the repeal, including the administration’s claimed savings and an EPA analysis described as showing higher fuel and maintenance costs over the long run. Same grill, two different stories about what is cooking.

The legal hinge (and why this is not ending with one headline)

EPA’s position is that without the endangerment finding it lacks authority under the specific Clean Air Act provision for motor vehicles, and it is pitching the move as the “best reading” of the law. The plaintiffs say the agency is dodging its duty and disregarding the scientific record. That means a long judicial road, no matter how loud the press releases get.

Let the case proceed. Let the judges do their job. But Americans should notice the bigger truth: when unelected systems can throttle your options through your tailpipe, your freedom is already idling at a red light with the check-engine light on.

The newsroom coffee tastes like burnt pennies today. Scanner chatter. Printer paper stacked like a warning you can trip over. And in the air-conditioned boardroom glass world where consequences rarely reach skin, the Environmental Protection Agency is selling an arson job as a paperwork tweak.

A coalition of public health and environmental groups has sued the Trump EPA over its repeal of the 2009 greenhouse gas “endangerment finding,” the scientific and legal foundation under the Clean Air Act for regulating climate pollution. The case is in the D.C. Circuit, and it targets EPA Administrator Lee Zeldin and a final rule dated February 12, 2026.

What happened: the legal predicate got yanked

On February 12, 2026, EPA finalized a rule rescinding the 2009 endangerment finding. EPA also says it repealed subsequent greenhouse gas standards for light-, medium-, and heavy-duty on-highway vehicles and engines. The agency’s argument is that without that endangerment finding, it lacks authority under Clean Air Act section 202(a) for those vehicle standards. EPA calls this the “single largest deregulatory action” and claims more than $1.3 trillion in savings.

Then came the lawsuit. The challengers argue the repeal is unlawful and ignores the scientific record that greenhouse gases endanger public health and welfare. Reporters have framed the stakes plainly: removing this underpinning could unravel major federal climate protections, including vehicle standards, and ripple into other regulatory arenas.

Translation: “endangerment” is government for “this hurts people”

Translation: “Endangerment finding” is the government’s formal way of saying: this pollution harms human health and welfare. Repealing it is the government’s formal way of saying: we are choosing not to see the harm. It is willful blindness with footnotes.

Translation: when EPA says it is “realigning” with its “best reading” of the law, it is trying to drag the Clean Air Act into a courthouse hallway and mug it for its authority.

Here is the mechanism: sabotage the trigger so the machine never turns on

Here is the mechanism: the Clean Air Act is built like a machine. Certain findings flip certain switches. “Endangerment” is one of those switches. If you can erase the finding, you can argue the duties never attach. That is not a policy disagreement. That is a system-level escape hatch.

EPA’s own description spells out the maneuver: rescind the finding, declare no 202(a) authority for vehicle greenhouse gas standards, and strip future obligations tied to measurement, control, and reporting for highway engines and vehicles. Not a scalpel. The main breaker.

Follow the money: “savings” for them, costs for you

Follow the money: EPA markets a giant number as “savings” and hopes nobody audits the assumptions. Meanwhile, the pattern stays familiar: privatize gains, socialize consequences, then argue about the spreadsheet while people breathe the outcome.

The quiet part: this is also a message to every scientist and regulator in the building. If your work produces obligations for powerful industries, your work will be put on trial. Not because it is wrong, but because it is inconvenient.

This fight now sits in the D.C. Circuit, where press releases go to become precedent. If you want accountability, do not shop for it in EPA PR. Demand audits, inspectors general heat, congressional oversight, state enforcement, courtroom injunctions, and organizing that makes deregulation politically expensive.

I could smell it before I even read it. That familiar odor of burnt paperwork and cold coffee, the kind of bureaucrat cologne you only get in a windowless office where somebody gets rich off a spreadsheet while the rest of us get a lecture.

According to emails obtained in a Nature investigation that Scientific American republished, staff at the National Institute of Allergy and Infectious Diseases (NIAID) have been told to scrub the words “biodefense” and “pandemic preparedness” from NIAID web pages. That is not a typo. That is a weather change.

The core fact (no fog machine)

• Instruction: Remove references to “biodefense” and “pandemic preparedness” from NIAID’s website, per the reporting.
• Context: Employees told the outlet this is part of a broader shake-up expected to deprioritize those areas.
• Money: NIAID is one of 27 NIH institutes and centers, with a reported budget around $6.6 billion. Scientific American reports roughly one-third currently supports projects tied to emerging infectious diseases and biodefense-type work.

And the reporting is clear about what we do not know yet: it is not fully clear what the final money moves will be. The word-scrub is described as an early step, with more changes expected, including reviews of grant portfolios. In Brick language: first they repaint the sign, then they start rearranging the furniture.

New management energy at NIH

Scientific American reports NIH Director Jay Bhattacharya described the restructure at a January 30 event as a complete transformation away from an older model that historically prioritized HIV, biodefense, and pandemic preparedness, and toward more focus on basic immunology and infectious diseases affecting Americans right now, rather than trying to predict future diseases.

NIAID is currently led by acting director Jeffery Taubenberger, according to Scientific American, after the previous director, Jeanne Marrazzo, was fired by the Trump administration.

Follow the grant gravy (carefully)

Scientific American reports NIH principal deputy director Matthew Memoli ordered more changes, including reviews of grants that fund biodefense and pandemic preparedness, in the coming weeks and months, according to employees who spoke to Nature. The reporting also says some changes could target the HIV division, including possible consolidation of branches, but it is not clear whether project counts or funding amounts will change.

On COVID politics, the reporting notes Republicans scrutinized NIAID and Anthony Fauci after public-health measures during the pandemic, while also clarifying Fauci and NIAID did not set policies like lockdowns and school closures.

Workforce churn and unanswered questions

Scientific American reports nearly one-fifth of NIH’s 2024 workforce of about 21,000 has been laid off or left voluntarily since Trump took office the previous January, and that an NIH spokesperson declined to say whether there will be further layoffs at NIAID as part of the restructure.

Bottom line: words matter, but results matter more. If this is focus and accountability, good. If it is political theater with a fresh paint job, America deserves receipts.

The newsroom coffee tastes like burned compliance training, and my inbox is a blinking fire alarm made of PDFs. Outside, the city is doing its usual: sirens, headlights, fluorescent lobby light bouncing off boardroom glass. Inside the federal machine, a different kind of noise just stopped. Not a bang. A click.

The Department of Energy has effectively backed off its much-hated attempt to choke research funding by capping indirect costs, the so-called overhead that keeps labs running. After months of ideological theater about ‘waste,’ DOE says the policy flashes that tried to force a blunt 15% ceiling are ‘no longer in effect,’ tied to a new FY2026 appropriations law. Universities and research groups are exhaling. For a second.

DOE says its 15% indirect-cost cap is no longer in effect after FY2026 spending law

This is the story in plain English: DOE tried to pay for the science but not the building where the science happens. Not the electricity. Not the safety officer who keeps graduate students from inhaling solvents. Not the cybersecurity staff who keeps your federally funded data from getting ransomed by a teenager with a botnet and a grudge.

Then Congress, via the FY2026 appropriations package that became Public Law 119-74, told DOE to knock it off and apply negotiated indirect cost rules the way they were applied in FY2024. DOE responded with a policy flash, PF-2026-30, saying the prior indirect-rate adjustment policy flashes are no longer in effect. The cap, at least in that form, is dead for now.

Do not confuse ‘dead for now’ with ‘the people who wanted it went away.’ They are still here. They just moved to a different hallway.

Translation: ‘Indirect costs’ is not a scam, it is the plumbing

Translation: indirect costs are the expenses you cannot attach to a single experiment but cannot avoid if you want a functioning research enterprise. Facilities and administrative costs. HVAC that keeps a clean room clean. Animal care compliance. Radiation safety. Grants accounting. Human subjects protections. The boring parts that prevent tragedy, fraud, and chaos.

When politicians and think-tank interns sneer about ‘overhead,’ they are not exposing corruption. They are marketing a budget cut using a word that sounds like a bad line item on a home reno estimate.

Here is the mechanism: Washington funds research through competitive awards, but the work is done inside institutions with real costs. The federal government negotiates indirect cost rates because the alternative is fantasy. The cap was an attempt to replace negotiated reality with a talking point: 15%, take it or leave it. That difference does not vanish. It just gets shoved onto universities, hospitals, and research partners, which then shove it onto workers, students, patients, and the next grant proposal that never gets written.

So when DOE says those policy flashes are no longer in effect, what they are really saying is: Congress reminded us that you cannot run a lab on vibes.

Follow the money: who benefits when you starve the lab to ‘save’ the grant?

Follow the money, because it always has fingerprints. The indirect-cost cap pitch is sold as taxpayer protection. But the practical effect is to weaken public and university research capacity, especially at institutions that do not have billion-dollar endowments sitting around like a private emergency fund.

Who wins when public science is cash-starved and unstable?

First: private firms that can poach talent and intellectual property on the cheap when university labs freeze hiring, shrink projects, or delay infrastructure upgrades. The cap turns steady research careers into temp work with lab coats.

Second: big donors and ideologues who want universities disciplined, not productive. A fragile institution is an obedient institution. You cannot argue for academic freedom while your finance office is begging Washington to stop lighting the grant rules on fire.

Third: the consultants, compliance vendors, and private intermediaries who thrive in chaos. When the rules shift every quarter, the people who profit are the ones selling ‘guidance’ to navigate the maze they lobbied to build.

The quiet part: the cap fight was never just about overhead. It is about power. About making the public research system small enough to control, and unstable enough to intimidate.

The rollback is real. The playbook is still on the table.

Yes, DOE backing off matters. It is a material retreat. It is also a case study in how this stuff actually gets done: an agency pushes an aggressive funding restriction, universities and associations sue, judges block parts of it, and eventually Congress writes language that forces a reset. That is not a civics fairy tale. That is a bruising, expensive, time-consuming defensive crouch that burns years of planning and millions in administrative effort.

And it is not isolated. NIH has been fighting similar indirect-cost cap battles, with courts weighing in and higher ed organizations mobilizing. You can hear the same drumbeat across agencies: label basic operating costs as waste, slash them, then call the resulting layoffs and project delays proof that public institutions cannot deliver.

Here is the mechanism again, because it is the trick: manufacture dysfunction, then privatize the ‘solution.’ Starve the lab, then complain it is hungry.

DOE’s move this month is a reminder that law can still act like law. Appropriations language can still bind an agency. But it is also a reminder of how close we are to governance by policy flash and ideological whim, where science is a bargaining chip and the people who keep the lights on are treated like freeloaders.

So take the win. Then keep your hand on your wallet.

Because next time, it might not be a blunt cap. It might be ‘program policy factors’ quietly punishing proposals with higher indirects. It might be delays, rescissions, or selective enforcement. It might be shifting work to contractors and private labs with sweetheart terms, because the public system was ‘too expensive’ after it was intentionally destabilized.

Accountability is not a vibe either. We need inspectors general, GAO reviews, aggressive congressional oversight, and litigation when agencies try to legislate by memo. We need universities to stop treating this as an inside-baseball budgeting dispute and start calling it what it is: an attack on the public capacity to do science in the public interest. And we need labor and researchers to organize like their jobs, and the country’s future, are on the same spreadsheet. They are.

DOE blinked today. Who is going to make sure they do not try the same stunt tomorrow?